Planned realisation and outcomes
CCPE aims to transform empirical approaches of producing the drugs of the future in a safe way. Both the time scale for drug development (now up to 12 years) as well as the excessive costs (up to 1 – 2 billion Euro per drug) will be significantly reduced. Research will focus on systematic product- and process development strategies, on the synthesis of structured materials, as well as on process scale-up, optimization and control strategies (PAT).
The center’s main impacts will be:
• Strengthening Austria’s position in the fields of life sciences, human technologies and engineering
• Reduced costs, consistent and reliable manufacturing of pharmaceuticals
• Faster, scientifically sound development of new products
• Development of highly trained human resources by establishing a master curriculum unique in Europe.
Dive into the research topics where Research Center Pharmaceutical Engineering (RCPE) (98888) is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.